# Dr. Blest-Hopley: Neuroscientist Specializing in Psychedelic & Cannabinoid Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/psychedelic-neuroscience-research-insights/ > **Published:** 2026-03-29T19:02:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:19:59-04:00 > **Clinical Summary:** Explore psychedelic neuroscience research and its clinical relevance in cannabinoid studies with Dr. Blest-Hopley’s latest findings and insights. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic NeuroscienceResearchPsychedelicsMechanismsEvidence Why This Matters Without access to the specific research content or findings, this represents the broader trend of neuroscientists increasingly studying cannabis and psychedelic mechanisms. The intersection of cannabinoid and psychedelic research may yield insights into shared neurological pathways relevant to therapeutic applications. Clinical Summary The referenced content appears to feature neuroscientist Dr. Blest-Hopley’s work on psychedelics and cannabinoids, though the specific research findings or clinical implications are not accessible from the provided link. Current neuroscience research in these areas typically focuses on receptor interactions, neuroplasticity mechanisms, and potential therapeutic targets. The field is rapidly evolving with increased academic interest in both cannabis and psychedelic medicine. Dr. Caplan’s Take “I can’t evaluate specific claims without seeing the actual research content. What matters most for clinicians is that we’re seeing more rigorous neuroscience research in both cannabis and psychedelics, which should eventually translate to better clinical guidance.” Clinical Perspective 🧠 Clinicians should look for peer-reviewed publications rather than social media content when evaluating cannabis or psychedelic research. As this field expands, focus on studies that translate neurobiological findings into clinically actionable protocols. The intersection of these research areas may inform future combination therapies or contraindication profiles. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20drblesthopley%20is%20a%20neuroscientist%20specializing%20in%20psychedelics%20%26%20cannabinoids%20re...%20%40drcaplan&url=https%3A//www.instagram.com/reel/DWerR8mDMxU/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.instagram.com/reel/DWerR8mDMxU/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20drblesthopley%20is%20a%20neuroscientist%20specializing%20in%20psychedelics%20%26%20cannabinoids%20re...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.instagram.com/reel/DWerR8mDMxU/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.instagram.com/reel/DWerR8mDMxU/](https://www.instagram.com/reel/DWerR8mDMxU/) Table of Contents - [FAQ](#FAQ)[What type of research is being discussed in this article?](#What_type_of_research_is_being_discussed_in_this_article) - [What is the clinical relevance rating for this research?](#What_is_the_clinical_relevance_rating_for_this_research) - [How does this research relate to cannabis medicine?](#How_does_this_research_relate_to_cannabis_medicine) - [What makes this research noteworthy for clinicians?](#What_makes_this_research_noteworthy_for_clinicians) - [What scientific areas does this research encompass?](#What_scientific_areas_does_this_research_encompass) - [Related](#Related) ## FAQ #### What type of research is being discussed in this article? This article focuses on neuroscience research related to psychedelics and their mechanisms of action. The research appears to be examining emerging findings in the field of psychedelic therapeutics. #### What is the clinical relevance rating for this research? This research has been assigned a Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This suggests the findings represent emerging developments worth monitoring closely by [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### How does this research relate to cannabis medicine? While the article is categorized under Cannabis News from CED Clinic, it appears to focus on psychedelic research mechanisms. The connection may involve similar neurological pathways or therapeutic applications shared between cannabis and psychedelic compounds. #### What makes this research noteworthy for clinicians? The research is classified as having “Notable Clinical Interest” due to emerging findings or policy developments in psychedelic medicine. This indicates potential future clinical applications or regulatory changes that healthcare providers should be aware of. #### What scientific areas does this research encompass? The research spans multiple scientific domains including neuroscience, psychedelics, and mechanisms of action. This interdisciplinary approach suggests comprehensive investigation into how psychedelic compounds affect the nervous system. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “drblesthopley is a neuroscientist specializing in psychedelics & cannabinoids research … – Instagram”, “url”: “https://www.instagram.com/reel/DWerR8mDMxU/”, “datePublished”: “2026-03-29T20:15:16Z”, “about”: “drblesthopley neuroscientist specializing psychedelics cannabinoids research”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) is more than a scientific pursuit—it's a pathway to better health, informed … Discover how [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) extends beyond science to impact health and policy, complementing psychedelic neuroscience studies. Read More [Joshua S. Bauchner Talks Psychedelics & Policy at National Cannabis Research …](https://cedclinic.com/psychedelics-policy-developments-2026-clinical-access/) Explore expert discussions on psychedelics and cannabis policy shaping the future of neuroscience research. [Explore Insights](https://cedclinic.com/psychedelics-policy-developments-2026-clinical-access/) [New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) Learn about recent [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) with potential [therapeutic benefits](https://cedclinic.com/therapeutic-benefits-of-thc/), highlighting the expanding neuroscience landscape. [Learn More](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).